leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC
No special treatment or protocol applies
Antibody 4295 against Brf2 was raised by immunizing rabbits with keyhole limpet hemocyanin coupled to synthetic peptides VSRSQQRGLRRVRDLC and SDSEIEQYLRTPQEVR, corresponding to human Brf2 residues 66-80 and 385-400, respectively. Antibody Target: BRF2
Brf2 is a component of an alternate form of the RNA Polymerase III transcription factor TFIIIB.
Donated by Dr. RJ White, The Beatson Institute for Cancer Research